| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 13,744 | 17,207 | 13,129 | 11,786 |
| Cost of product revenue | 1,032 | 1,140 | 1,088 | 685 |
| Research and development | 30,731 | 10,048 | 8,046 | 9,573 |
| Selling, general and administrative | 25,117 | 18,574 | 15,018 | 16,588 |
| Total operating costs and expenses | 56,880 | 29,762 | 24,152 | 26,846 |
| Loss from operations | -43,136 | -12,555 | -11,023 | -15,060 |
| Other income, net | 1,736 | 1,485 | 553 | 400 |
| Total other income, net | 1,736 | 1,485 | 553 | 400 |
| Net loss | -41,400 | -11,070 | -10,470 | -14,660 |
| Unrealized gain (loss), net of tax | 4 | 0 | -2 | -26 |
| Comprehensive loss | -41,396 | -11,070 | -10,472 | -14,686 |
| Basic EPS | -0.13 | -0.04 | -0.06 | -0.12 |
| Diluted EPS | -0.13 | -0.04 | -0.06 | -0.12 |
| Basic Average Shares | 309,670,101 | 278,782,132 | 170,169,865 | 120,016,132 |
| Diluted Average Shares | 309,670,101 | 278,782,132 | 170,169,865 | 120,016,132 |
Invivyd, Inc. (IVVD)
Invivyd, Inc. (IVVD)